Menopause

Virtual Care Provider Midi Health Secures $60M in Series B Funding to Advance Perimenopause and Menopause Care

Midi Health, a virtual healthcare provider for perimenopause and menopause, has successfully raised $60 million in a Series B funding round. This latest injection of capital, led by Emerson Collective, raises the company’s total funding to an impressive $100 million. Additional investors include GV (Google Ventures), who led the previous funding round, along with Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel…

Included Health Adds Virtual Specialty Care Services Starting with Menopause, Metabolic Health & Cancer

Healthcare company Included Health has unveiled its latest innovation: the Specialty Care Clinic. This novel clinic model aims to swiftly connect individuals with expert medical opinions, primary care, mental health support, and navigation services, specifically targeting specialty care needs, including menopause-related health concerns. The San Francisco-based company has identified a critical gap in the healthcare landscape concerning specialty care access, particularly for…

Seed Health Introduces Computational Biology Platform, CODA, to Advance Menopause Research

Seed Health has launched CODA, a computational biology platform aimed at discovering and developing precision probiotics and microbiome-directed interventions. Powered by the Human Phenotype Project, the world’s most extensive multi-omics dataset, CODA focuses on advancing research in metabolic health, brain health, menopause, and longevity. CODA integrates over three million phenotypic data points from more than 13,000 individuals across 40,000 cumulative subject years.…

Menopause Virtual Clinic Midi Health and Caregiver Support Platform Cleo Partner to Enhance Support for Women during Midlife Hormonal Transition

Midi Health, a virtual care clinic specializing in women’s health during perimenopause and menopause, has teamed up with Cleo, a global caregiving platform, to provide comprehensive support for women facing hormonal changes. The collaboration aims to address the specific healthcare needs of women during this critical phase of their lives. The partnership between Midi Health and Cleo allows for personalized guidance and…

Bayer’s Elinzanetant Shows Promise in Alleviating Vasomotor Symptoms Associated with Menopause

Bayer has announced positive topline results from the Phase III OASIS 3 study, shedding light on the potential efficacy and safety of their investigational compound, elinzanetant, in treating moderate to severe vasomotor symptoms (VMS) linked to menopause. These findings bolster the case for elinzanetant’s marketing authorization submissions, which Bayer plans to present to health authorities. In the OASIS 3 study, elinzanetant demonstrated…

Lisa Health Study Unveils Workplace Realities: Menopause’s Impact on Women’s Careers

SRI (formerly Stanford Research Institute) and Lisa Health, the company behing the Midday menopause app, recently published a study shedding light on the often-overlooked challenges faced by menopausal women in the workforce. The study, conducted across the United States with 351 working women aged 40–65, aimed to understand the intersection of menopause and professional life. “There is a notable gap between desired…

Elektra Health Adds $3.3M in Seed Funding to Grow Its Platform for Evidence-based Menopause Care

Elektra Health, a digital health company focusing on menopause care, has announced a $3.3M funding round led by UPMC Enterprises, the innovation and venture capital arm of UPMC. The round, which saw participation from Wavemaker 360 and prior investors Flare Capital Partners and Seven Seven Six Fund, aims to bridge the menopause care gap through a comprehensive care model. The new funding…

From Hot Flashes to ‘Not Flashes’: Astellas Airs New VEOZAH TV Spot During This Year’s Super Bowl

This year pharma company Astellas is returning to the Superbowl to help educate game viewers about VEOZAH and vasomotor symptoms (VMS), the most commonly reported menopause symptoms. The “Fewer Hot Flashes, More Not Flashes” ad features women experiencing common moderate to severe hot flash and night sweat moments that impact their daily lives. VEOZAH, a nonhormonal treatment recently greenlit by the FDA,…